CRMD: Strong revenue growth, pipeline expansion, and financial flexibility drive continued value creation
A diversified specialty pharma business with a strong institutional focus, robust product portfolio, and scalable commercial platform is delivering sustained revenue growth and profitability. DefenCath and REZZAYO drive market leadership, with pipeline expansions targeting large new markets and str…
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.